A recombinant bacterium for producing nicotinamide, its preparation method and application

By constructing recombinant bacteria expressing specific enzymes and using anthranilic acid as a substrate, the problems of low yield and high cost in existing nicotinamide preparation methods have been solved, achieving efficient, green and environmentally friendly nicotinamide production.

CN122405520BActive Publication Date: 2026-11-10JIANGXI VIABLIFE BIOPHARMACEUTICAL CO LTD +1
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202610839471.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2026-06-11
Publication Date
2026-11-10
Estimated Expiration
2046-06-11

AI Technical Summary

Technical Problem

Existing methods for preparing nicotinamide suffer from low yield, low purity, harsh reaction conditions, and the use of the highly toxic substrate 3-cyanopyridine, which limits its industrial application and results in high costs.

Method used

By constructing recombinant bacteria expressing exogenous p-hydroxybenzoic acid hydroxylase, 3-hydroxy-oanaminobenzoic acid 3,4-dioxygenase, phenolic acid decarboxylase, and aspartate amino ligase, nicotinamide was synthesized through biotransformation using the inexpensive substrate ananaminobenzoic acid.

Benefits of technology

It has achieved efficient and environmentally friendly nicotinamide production, with high output and low cost, and has good prospects for industrial application.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN122405520B_ABST
    Figure CN122405520B_ABST
Patent Text Reader

Abstract

This invention discloses a recombinant bacterium for producing nicotinamide, its preparation method, and its applications, belonging to the field of biotechnology. The recombinant bacterium of this invention is constructed by introducing exogenous genes encoding p-hydroxybenzoic acid hydroxylase, 3-hydroxy-annaminobenzoic acid 3,4-dioxygenase, phenolic acid decarboxylase, and aspartate aminoligase. This recombinant bacterium can convert sodium annaminobenzoate into nicotinamide using sodium annaminobenzoate as a substrate. Annaminobenzoic acid, the substrate, is inexpensive, can be obtained through biological methods, and the raw material preparation process is non-toxic and environmentally friendly, making it an ideal substrate. Furthermore, the enzymes selected in this invention have advantages such as high activity and strong optical specificity. Therefore, the production of nicotinamide using the recombinant bacterium of this invention has the characteristics of high production efficiency, environmental friendliness, and low cost, and has good prospects for industrial application.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of biotechnology, and more specifically, to a recombinant bacterium for producing nicotinamide, its preparation method, and its application. Background Technology

[0002] Nicotinamide, also known as nicotinamide, belongs to the B vitamins and is widely distributed in nature, with abundant content in cereal germ, dried yeast, meat, and peanuts. Nicotinamide is an important component of the coenzymes nicotinamide adenine dinucleotide and nicotinamide adenine dinucleotide phosphate, directly participating in various redox reactions in the body. Nicotinamide can be used to treat skin diseases, diabetes, and neurological disorders. It is also used as a feed additive to improve the disease resistance and growth rate of livestock and poultry, which is its largest application area. Furthermore, nicotinamide is widely used as a cosmetic ingredient in the cosmetic industry. Therefore, with the continuous development of related industries and consumption upgrades, the market demand for nicotinamide is showing a steady growth trend, highlighting its increasing importance.

[0003] Nicotinamide can be prepared by chemical synthesis, which involves synthesizing 3-cyanopyridine from 3-methylpyridine via ammonia oxidation, followed by chemical hydrolysis to synthesize nicotinamide. However, this method suffers from low yield, low purity, and demanding reaction conditions, and has been gradually phased out. Biotransformation, on the other hand, offers advantages such as high specificity, environmental friendliness, mild reaction conditions, and the elimination of the need for multi-step separation and purification, and has thus attracted widespread attention.

[0004] Currently, scholars both domestically and internationally have reported various biochemical routes for the preparation of nicotinamide. One such route uses 3-cyanopyridine as a substrate, which is converted to nicotinamide by a nitrile hydratase. Chinese patent CN109593750B discloses a nitrile hydratase mutant. The newly obtained mutant enzyme exhibits better temperature tolerance and product tolerance. By converting 3-cyanopyridine with recombinant E. coli containing the mutant, the yield and concentration of nicotinamide are significantly improved.

[0005] The nicotinamide preparation routes reported above all use 3-cyanopyridine as a substrate. However, 3-cyanopyridine is mainly synthesized by chemical methods and has high toxicity. Even a small amount of residue can have a significant impact on the quality of the product. In addition, the substrate is expensive and has limited sources, which hinders its large-scale industrial application. Therefore, there is an urgent need in this field to develop a green, environmentally friendly, and low-cost method for preparing nicotinamide.

[0006] In view of this, the present invention is proposed. Summary of the Invention

[0007] The purpose of this invention is to provide a recombinant bacterium for producing nicotinamide, its preparation method and application. This recombinant bacterium can efficiently convert the inexpensive substrate anthranilic acid into nicotinamide by expressing exogenous p-hydroxybenzoic acid hydroxylase, 3-hydroxy-anthranilic acid 3,4-dioxygenase, phenolic acid decarboxylase and aspartate amino ligase.

[0008] This invention is implemented as follows: The synthetic route of nicotinamide in this invention is as follows: Figure 1 As shown: anthranilic acid is converted to 3-hydroxyanthranilic acid by p-hydroxybenzoic acid hydroxylase (PHBH), 3-hydroxyanthranilic acid is converted to quinolinic acid by 3-hydroxyanthranilic acid 3,4-dioxygenase (HAAO), nicotinic acid is obtained by phenolic acid decarboxylase (PAD), and nicotinamide is obtained by aspartate amino ligase (AAL). The ATP and coenzyme NADPH required for the reaction process are provided by the strain's metabolism of glucose.

[0009] Based on the above synthetic route, this invention provides a recombinant bacterium capable of expressing PHBH, HAAO, PAD and AAL, which is used as a whole-cell catalyst for the production of nicotinamide. This method has high yield and production efficiency.

[0010] During the research process, this invention discovered that PHBH, HAAO, PAD, and AAL from different sources have a significant impact on the production efficiency of nicotinamide.

[0011] Among them, PHBH includes those derived from Streptomyces coelicolor SCPHBH (Genbank ID CAB89456.1), and from Burkholderia pseudomallei The amino acid sequences of BpPHBH and ScPHBH (Genbank ID CAM9023754.1) are shown in SEQ ID NO.2, and the amino acid sequence of BpPHBH is shown in SEQ ID NO.4.

[0012] HAAO includes sources Rhodococcus erythropolis ReHAAO (Genbank ID QIP37767.1), and sources from Flavobacterium glucosi The amino acid sequences of FgHAAO (Genbank ID WP_417998388.1) and ReHAAO are shown in SEQ ID NO.6, and the amino acid sequence of FgHAAO is shown in SEQ ID NO.8.

[0013] PAD includes sources Heyndrickxia coagulans HcPAD (Genbank ID AEP00765.1), and from Lactococcus cremorisThe amino acid sequences of LcPAD (Genbank ID BBC75390.1) and HcPAD are shown in SEQ ID NO.10, and the amino acid sequence of LcPAD is shown in SEQ ID NO.12.

[0014] AAL includes sources Phocaeicola salanitronis PsAAL (Genbank ID ADY34669.1), and from Acetivibrio thermocellus The amino acid sequences of AtAAL and PsAAL (Genbank ID ALX09178.1) are shown in SEQ ID NO.14, and the amino acid sequence of AtAAL is shown in SEQ ID NO.16.

[0015] This invention found in experiments that the combination of PHBH, HAAO, PAD, and AAL from the aforementioned sources resulted in higher nicotinamide production efficiency. Furthermore, after obtaining the amino acid sequences of PHBH, HAAO, PAD, and AAL from the aforementioned sources, codon optimization was performed based on the starting strain's preferences.

[0016] In some embodiments, the starting strain includes, but is not limited to, *Escherichia coli*. The specific type of *E. coli* may be... Escherichia coli BL21(DE3), Escherichia coli DH5α or Escherichia coli XL-Blue. In addition, other commonly used model strains in the art can also be used. Referring to the construction method of this invention, simply replacing the starting strain also falls within the scope of protection of this invention.

[0017] Specifically, the nucleotide sequence of ScPHBH is shown in SEQ ID NO.1, the nucleotide sequence of BpPHBH is shown in SEQ ID NO.3; the nucleotide sequence of ReHAAO is shown in SEQ ID NO.5, the nucleotide sequence of FgHAAO is shown in SEQ ID NO.7; the nucleotide sequence of HcPAD is shown in SEQ ID NO.9, the nucleotide sequence of LcPAD is shown in SEQ ID NO.11; the nucleotide sequence of PsAAL is shown in SEQ ID NO.13, and the nucleotide sequence of AtAAL is shown in SEQ ID NO.15.

[0018] Correspondingly, the preparation method of the above-mentioned recombinant bacteria includes: inserting the genes encoding PHBH, HAAO, PAD and AAL into the expression vector to obtain the recombinant vector, and then introducing the recombinant vector into Escherichia coli to obtain the recombinant bacteria.

[0019] In some embodiments, the expression vectors described above include pCDFDuet-1 and pACYCDuet-1 plasmids.

[0020] The recombinant Escherichia coli of this invention co-expresses the encoding genes of four enzymes through two plasmids. Optionally, pCDFDuet-1 is loaded with PHBH and HAAO, and pACYCDuet-1 is loaded with PAD and AAL. Then, the two recombinant plasmids are transformed into the starting strain to obtain the recombinant bacteria.

[0021] Different plasmids loaded with the enzymes from different sources resulted in varying yields of nicotinamide. Recombinant vectors capable of synthesizing high yields of nicotinamide include pCDFDuet-ScPHBH-ReHAAO, pACYCDuet-HcPAD-PsAAL, pCDFDuet-BpPHBH-ReHAAO, pCDFDuet-ScPHBH-FgHAAO, pACYCDuet-LcPAD-PsAAL, pACYCDuet-HcPAD-AtAAL, pCDFDuet-BpPHBH-FgHAAO, and pCDFDuet-BpPHBH-ReHAAO.

[0022] More preferably, the recombinant vector is a combination of pCDFDuet-ScPHBH-ReHAAO and pACYCDuet-HcPAD-AtAAL.

[0023] Based on this, the recombinant bacteria provided by the present invention can be used to catalyze the synthesis of nicotinamide; and / or, to prepare products catalyzed by the synthesis of nicotinamide.

[0024] Therefore, the present invention can provide a product for the catalytic synthesis of nicotinamide, which can be a biocatalyst.

[0025] In some embodiments, the biocatalyst contains the aforementioned recombinant bacteria.

[0026] The present invention can also provide a method for producing nicotinamide using the above-mentioned recombinant bacteria, which is: adding the above-mentioned recombinant bacteria to a solution containing sodium anthranilate for whole-cell catalysis to obtain nicotinamide.

[0027] In some embodiments, the recombinant bacteria are induced to undergo culture before whole-cell transformation. This induction culture process involves inoculating the recombinant bacteria into LB medium containing 30–60 mg / L streptomycin and 30–60 mg / L chloramphenicol, culturing to obtain a seed culture, and then inoculating the seed culture into fresh LB medium until the bacterial concentration reaches OD0.05. 600nm When the concentration reaches 0.6~0.8, add an inducer, and after induction, separate and wash to obtain wet bacterial cells.

[0028] In some embodiments, the culture conditions for the recombinant bacteria are: temperature of 32-38°C, rotation speed of 150-250 rpm, and culture time of 10-16 h.

[0029] In some embodiments, the culture conditions for the seed culture are: temperature of 32~38℃ and rotation speed of 150~250rpm.

[0030] In some embodiments, the induction conditions are: 0.2-0.6 mM IPTG inducer, temperature of 25-30°C, and time of 10-16 h.

[0031] In some embodiments, the whole-cell transformation system includes: sodium anthranilate 1~80 g / L, ammonium chloride 5~35 g / L, glucose 5~80 g / L, and wet cells of recombinant bacteria 1~30 g / L.

[0032] In some embodiments, the pH of the whole-cell transformation system is 6.0-9.0, the temperature is 15-40°C, the rotation speed is 100-250 rpm, and the reaction time is 8-24 h.

[0033] The present invention has the following beneficial effects: This invention constructs a recombinant *Escherichia coli* bacterium by introducing exogenous p-hydroxybenzoic acid hydroxylase, 3-hydroxy-o-aminobenzoic acid 3,4-dioxygenase, phenolic acid decarboxylase, and aspartate aminoligase. This recombinant bacterium can convert sodium an-aminobenzoate into nicotinamide using sodium an-aminobenzoate as a substrate. An-aminobenzoic acid is an inexpensive substrate that can be obtained biologically, and the raw material preparation process is non-toxic and environmentally friendly, making it an ideal substrate. Furthermore, the enzymes selected in this invention have advantages such as high activity and strong optical specificity. Therefore, the production of nicotinamide using this recombinant bacterium is characterized by high production efficiency, environmental friendliness, and low cost, and has good prospects for industrial application. Attached Figure Description

[0034] To more clearly illustrate the technical solutions of the embodiments of the present invention, the accompanying drawings used in the embodiments will be briefly introduced below. It should be understood that the following drawings only show some embodiments of the present invention and should not be regarded as a limitation on the scope. For those skilled in the art, other related drawings can be obtained based on these drawings without creative effort.

[0035] Figure 1 This is the synthetic route for nicotinamide in this invention. Detailed Implementation

[0036] To make the objectives, technical solutions, and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below. Where specific conditions are not specified in the embodiments, conventional conditions or conditions recommended by the manufacturer shall apply. Reagents or instruments whose manufacturers are not specified are all conventional products that can be purchased commercially.

[0037] The features and performance of the present invention will be further described in detail below with reference to embodiments.

[0038] 1. Selection of bacteria and plasmids pCDFDuet-1 plasmid and pACYCDuet-1 plasmid purchased from Novagen. Escherichia coli BL21 Escherichia coli DH5α, Escherichia coli XL-Blue.

[0039] 2. Enzyme selection (1) Selection of p-hydroxybenzoic acid hydroxylase The amino acid sequences of p-hydroxybenzoic acid hydroxylases ScPHBH and BpPHBH were obtained from the NCBI database, as shown in SEQ ID NO.2 and SEQ ID NO.4, respectively. Codon optimization was performed based on E. coli preferences, and then the optimized nucleotide sequences were artificially synthesized by General Biotechnology (Anhui) Co., Ltd. The obtained nucleotide sequences are shown in SEQ ID NO.1 and SEQ ID NO.3, respectively, and EcoRI and HindIII restriction sites were added to both ends of the nucleotide sequences.

[0040] The steps for artificially synthesizing the above nucleotide sequence are as follows: S1. Sequence Processing: Receive gene sequences, optimize codons, split fragments, and add cloning sites; S2. Oligonucleotide synthesis: Chemical synthesis of short DNA single strands followed by purification and quality control; S3. Fragment splicing: splicing together into a complete gene through PCR or seamless assembly; S4. Vector cloning: The complete gene is inserted into a vector and transformed into E. coli culture; S5. Quality control and verification: PCR, enzyme digestion, and full-length sequencing to check the sequence; S6. Extract plasmids.

[0041] (2) Selection of 3-hydroxy-o-aminobenzoic acid 3,4-dioxygenase The amino acid sequences of 3-hydroxy-o-aminobenzoic acid 3,4-dioxygenase ReHAAO and FgHAAO were obtained from the NCBI database, as shown in SEQ ID NO.6 and SEQ ID NO.8, respectively. Codon optimization was performed based on E. coli preference, and then General Biotech (Anhui) Co., Ltd. was commissioned to perform artificial synthesis based on the optimized nucleotide sequences. The nucleotide synthesis method was the same as described in (1), and the obtained nucleotide sequences were shown in SEQ ID NO.5 and SEQ ID NO.7, respectively. Enzyme cleavage sites NdeI and XhoI were added to both ends of the nucleotide sequences.

[0042] (3) Selection of phenolic acid decarboxylase The amino acid sequences of phenolic acid decarboxylases HcPAD and LcPAD were obtained from the NCBI database, as shown in SEQ ID NO.10 and SEQ ID NO.12, respectively. Codon optimization was performed based on E. coli preferences. Then, General Biotech (Anhui) Co., Ltd. was commissioned to perform artificial synthesis based on the optimized nucleotide sequences. The nucleotide synthesis method was the same as described in (1). The obtained nucleotide sequences are shown in SEQ ID NO.9 and SEQ ID NO.11, respectively. EcoRI and HindIII restriction sites were added to both ends of the nucleotide sequences.

[0043] (4) Selection of aspartate amino ligase The amino acid sequences of aspartate amino ligases PsAAL and AtAAL were obtained from the NCBI database, as shown in SEQ ID NO.14 and SEQ ID NO.16. Codon optimization was performed based on E. coli preferences, and then General Biotech (Anhui) Co., Ltd. was commissioned to perform artificial synthesis based on the optimized nucleotide sequences. The nucleotide synthesis method was the same as described in (1). The obtained nucleotide sequences are shown in SEQ ID NO.13 and SEQ ID NO.15, respectively, and restriction sites NdeI and XhoI were added to both ends of the nucleotide sequences.

[0044] 3. Construction of a four-enzyme co-expression system and cell culture One enzyme from each of the selected four groups—p-hydroxybenzoic acid hydroxylase, 3-hydroxy-an-aminobenzoic acid 3,4-dioxygenase, phenolic acid decarboxylase, and aspartate aminoligase—was chosen for co-expression. The encoding genes of all four enzymes were co-expressed using the pCDFDuet-1 and pACYCDuet-1 double plasmids; pCDFDuet-1 contained p-hydroxybenzoic acid hydroxylase and 3-hydroxy-an-aminobenzoic acid 3,4-dioxygenase, while pACYCDuet-1 contained phenolic acid decarboxylase and aspartate aminoligase. After obtaining the co-expression recombinant plasmids, both recombinant plasmids were simultaneously transformed into *E. coli*. Escherichia coli Positive transformants, or recombinant Escherichia coli, were obtained from BL21 competent cells using plates containing streptomycin and chloramphenicol. The recombinant bacteria were then inoculated into fresh liquid culture medium, induced, and centrifuged to obtain wet bacterial cells.

[0045] 4. Whole-cell catalytic synthesis of nicotinamide from anthranilic acid Transformation system: Sodium anthranilate concentration 1–80 g / L, ammonium chloride concentration 5–35 g / L, glucose concentration 5–80 g / L, PBS solution as solvent, pH adjusted to 6.0–9.0, fresh cell mass 1–30 g / L, then transformed at 15–40℃ and 200 rpm for 8–24 h. Nicotinamide yield was determined by liquid chromatography after transformation.

[0046] 5. Sample detection and analysis The conversion solution was analyzed using a Shimadzu 2030C high-performance liquid chromatograph (HPLC). The chromatographic conditions were as follows: mobile phase: methanol:water (v / v=1:1), Inertsustain C18 column (4.6×250 mm, 5 μm), flow rate: 1 mL / min, column temperature: 30℃, injection volume: 20 μL, and detection wavelength: 259 nm.

[0047] Example 1 Construction of recombinant Escherichia coli The fully synthesized PHBH recombinant plasmid and pCDFDuet-1 vector were double-digested with restriction endonucleases EcoRI and HindIII, respectively. The fully synthesized HAAO recombinant plasmid and pCDFDuet-1 vector were double-digested with restriction endonucleases NdeI and XhoI, respectively. PHBH and HAAO from different sources were then ligated into the pCDFDuet vector in pairs using T4 DNA ligase to obtain recombinant plasmid 1. The fully synthesized PAD recombinant plasmid and pACYCDuet-1 vector were double-digested with restriction endonucleases EcoRI and HindIII, respectively. The fully synthesized AAL recombinant plasmid and pACYCDuet-1 vector were then double-digested with restriction endonucleases NdeI and XhoI, respectively. PAD and AAL from different sources were then ligated into the pACYCDuet-1 vector in pairs using T4 DNA ligase to obtain recombinant plasmid 2. Recombinant plasmid 1 and recombinant plasmid 2 were then combined in pairs and transformed into... E.coli Recombinant Escherichia coli was obtained from BL21(DE3) competent cells.

[0048] Example 2 Induction culture of recombinant Escherichia coli Recombinant *E. coli* was inoculated into LB medium containing 50 mg / L streptomycin and 50 mg / L chloramphenicol, and cultured at 37°C and 200 rpm for 12 h to obtain a seed culture. The seed culture was then inoculated into fresh LB medium at a 2% inoculation rate and cultured at 37°C and 200 rpm until the bacterial concentration reached OD500. 600nmWhen the concentration reaches 0.7, add 0.5 mM IPTG, induce at 28℃ for 8 h, centrifuge at 4000 rpm for 10 min, discard the supernatant, wash the wet bacterial cells twice with 0.9% physiological saline, centrifuge, and set aside.

[0049] Example 3 Comparison of transformation capabilities of various recombinant Escherichia coli strains The collected recombinant E. coli were resuspended in a 50 mL system with a final cell concentration of 30 g / L, sodium anthranilate concentration of 80 g / L, ammonium chloride concentration of 35 g / L, glucose concentration of 80 g / L, and PBS solution at pH 8.0. The reaction was carried out at 30°C with a shaking speed of 200 rpm for 24 h. After transformation, the yield of nicotinamide was determined by HPLC.

[0050] Table 1 Comparison of nicotinamide yields for various recombinant strains

[0051] The yield results in Table 1 show that the recombinant bacteria... E.coli The highest yield of nicotinamide was achieved by using sodium anthranilate in BL21(DE3) / pCDFDuet-ScPHBH-ReHAAO+pACYCDuet-HcPAD-AtAAL, therefore, the reaction conditions were screened and validated based on this bacterium.

[0052] Example 4 According to the induction expression method described in Example 2, E.coli After BL21(DE3) / pCDFDuet-ScPHBH-ReHAAO+pACYCDuet-HcPAD-AtAAL induction, bacterial cells were collected and placed in a 50 mL system with a final cell concentration of 1 g / L, sodium anthranilate concentration of 1 g / L, ammonium chloride concentration of 5 g / L, glucose concentration of 5 g / L, and PBS solution at pH 8.0. The reaction was carried out at 30℃ with a shaking speed of 200 rpm for 24 h. HPLC analysis showed that the nicotinamide yield was 0.75 g / L.

[0053] Example 5 According to the induction expression method described in Example 2, E.coliAfter BL21(DE3) / pCDFDuet-ScPHBH-ReHAAO+pACYCDuet-HcPAD-AtAAL induction, bacterial cells were collected and placed in a 50 mL system with a final cell concentration of 3 g / L, sodium anthranilate concentration of 10 g / L, ammonium chloride concentration of 5 g / L, glucose concentration of 11 g / L, and PBS solution at pH 8.0. The reaction was carried out at 35℃ with a shaking speed of 200 rpm for 24 h. HPLC analysis showed that the nicotinamide yield was 7.6 g / L.

[0054] Example 6 According to the induction expression method described in Example 2, E.coli After BL21(DE3) / pCDFDuet-ScPHBH-ReHAAO+pACYCDuet-HcPAD-AtAAL induction, bacterial cells were collected and placed in a 50 mL system with a final cell concentration of 9 g / L, sodium anthranilate concentration of 24 g / L, ammonium chloride concentration of 9 g / L, glucose concentration of 25 g / L, and PBS solution at pH 8.0. The reaction was carried out at 30℃ with a shaking speed of 200 rpm for 24 h. HPLC analysis showed that the nicotinamide yield was 17.9 g / L.

[0055] Example 7 According to the induction expression method described in Example 2, E.coli After BL21(DE3) / pCDFDuet-ScPHBH-ReHAAO+pACYCDuet-HcPAD-AtAAL induction, bacterial cells were collected and placed in a 50 mL system with a final cell concentration of 12 g / L, sodium anthranilate concentration of 34 g / L, ammonium chloride concentration of 13 g / L, glucose concentration of 34 g / L, and PBS solution at pH 8.0. The reaction was carried out at 30℃ with a shaking speed of 200 rpm for 24 h. HPLC analysis showed that the nicotinamide yield was 25.4 g / L.

[0056] Example 8 According to the induction expression method described in Example 2, E.coliAfter BL21(DE3) / pCDFDuet-ScPHBH-ReHAAO+pACYCDuet-HcPAD-AtAAL induction, bacterial cells were collected and placed in a 50 mL system with a final cell concentration of 18 g / L, sodium anthranilate concentration of 45 g / L, ammonium chloride concentration of 18 g / L, glucose concentration of 44 g / L, and PBS solution at pH 8.0. The reaction was carried out at 30℃ with a shaking speed of 200 rpm for 24 h. HPLC analysis showed that the nicotinamide yield was 33.9 g / L.

[0057] Example 9 According to the induction expression method described in Example 2, E.coli After BL21(DE3) / pCDFDuet-ScPHBH-ReHAAO+pACYCDuet-HcPAD-AtAAL induction, bacterial cells were collected and placed in a 50 mL system with a final cell concentration of 21 g / L, sodium anthranilate concentration of 58 g / L, ammonium chloride concentration of 23 g / L, glucose concentration of 57 g / L, and PBS solution at pH 8.0. The reaction was carried out at 30℃ with a shaking speed of 200 rpm for 24 h. HPLC analysis showed that the nicotinamide yield was 43.9 g / L.

[0058] Example 10 According to the induction expression method described in Example 2, E.coli After BL21(DE3) / pCDFDuet-ScPHBH-ReHAAO+pACYCDuet-HcPAD-AtAAL induction, bacterial cells were collected and placed in a 50 mL system with a final cell concentration of 27 g / L, sodium anthranilate concentration of 75 g / L, ammonium chloride concentration of 31 g / L, glucose concentration of 76 g / L, and PBS solution at pH 8.0. The reaction was carried out at 30℃ with a shaking speed of 200 rpm for 24 h. HPLC analysis showed that the nicotinamide yield was 56.1 g / L.

[0059] Example 11 According to the induction expression method described in Example 2, E.coliAfter BL21(DE3) / pCDFDuet-ScPHBH-ReHAAO+pACYCDuet-HcPAD-AtAAL induction, bacterial cells were collected and placed in a 50 mL system with a final cell concentration of 30 g / L, sodium anthranilate concentration of 40 g / L, ammonium chloride concentration of 14 g / L, glucose concentration of 39 g / L, and PBS solution at pH 8.0. The reaction was carried out at 30℃ with a shaking speed of 200 rpm for 12 h. HPLC analysis showed that the nicotinamide yield was 29.8 g / L.

[0060] Example 12 According to the induction expression method described in Example 2, E.coli After BL21(DE3) / pCDFDuet-ScPHBH-ReHAAO+pACYCDuet-HcPAD-AtAAL induction, bacterial cells were collected and placed in a 50 mL system with a final cell concentration of 30 g / L, sodium anthranilate concentration of 24 g / L, ammonium chloride concentration of 8 g / L, glucose concentration of 26 g / L, and PBS solution at pH 8.0. The reaction was carried out at 30℃ with a shaking speed of 200 rpm for 8 h. HPLC analysis showed that the nicotinamide yield was 18.2 g / L.

[0061] Example 13 According to the induction expression method described in Example 2, E.coli After BL21(DE3) / pCDFDuet-ScPHBH-ReHAAO+pACYCDuet-HcPAD-AtAAL induction, bacterial cells were collected and placed in a 50 mL system with a final cell concentration of 24 g / L, sodium anthranilate concentration of 27 g / L, ammonium chloride concentration of 10 g / L, glucose concentration of 25 g / L, and PBS solution at pH 8.0. The reaction was carried out at 30℃ with a shaking speed of 200 rpm for 10 h. HPLC analysis showed that the nicotinamide yield was 20.2 g / L.

[0062] Example 14 According to the induction expression method described in Example 2, E.coliAfter BL21(DE3) / pCDFDuet-ScPHBH-ReHAAO+pACYCDuet-HcPAD-AtAAL induction, bacterial cells were collected and placed in a 50 mL system with a final cell concentration of 21 g / L, sodium anthranilate concentration of 39 g / L, ammonium chloride concentration of 15 g / L, glucose concentration of 41 g / L, and PBS solution at pH 8.0. The reaction was carried out at 30℃ with a shaking speed of 200 rpm for 17 h. HPLC analysis showed that the nicotinamide yield was 29.6 g / L.

[0063] Example 15 According to the induction expression method described in Example 2, E.coli After BL21(DE3) / pCDFDuet-ScPHBH-ReHAAO+pACYCDuet-HcPAD-AtAAL induction, bacterial cells were collected and placed in a 50 mL system with a final cell concentration of 18 g / L, sodium anthranilate concentration of 22 g / L, ammonium chloride concentration of 8 g / L, glucose concentration of 23 g / L, and PBS solution at pH 6.0. The reaction was carried out at 35℃ with a shaking speed of 200 rpm for 12 h. HPLC analysis showed that the nicotinamide yield was 16.6 g / L.

[0064] Example 16 According to the induction expression method described in Example 2, E.coli After BL21(DE3) / pCDFDuet-ScPHBH-ReHAAO+pACYCDuet-HcPAD-AtAAL induction, bacterial cells were collected and placed in a 50 mL system with a final cell concentration of 15 g / L, sodium anthranilate concentration of 19 g / L, ammonium chloride concentration of 7 g / L, glucose concentration of 20 g / L, and PBS solution at pH 7.0. The reaction was carried out at 35℃ with a shaking speed of 200 rpm for 12 h. HPLC analysis showed that the nicotinamide yield was 14.2 g / L.

[0065] Example 17 According to the induction expression method described in Example 2, E.coliAfter BL21(DE3) / pCDFDuet-ScPHBH-ReHAAO+pACYCDuet-HcPAD-AtAAL induction, bacterial cells were collected and placed in a 50 mL system with a final cell concentration of 12 g / L, sodium anthranilate concentration of 17 g / L, ammonium chloride concentration of 6 g / L, glucose concentration of 18 g / L, and PBS solution at pH 7.5. The reaction was carried out at 35℃ with a shaking speed of 200 rpm for 12 h. HPLC analysis showed that the nicotinamide yield was 12.8 g / L.

[0066] Example 18 According to the induction expression method described in Example 2, E.coli After BL21(DE3) / pCDFDuet-ScPHBH-ReHAAO+pACYCDuet-HcPAD-AtAAL induction, bacterial cells were collected and placed in a 50 mL system with a final cell concentration of 6 g / L, sodium anthranilate concentration of 10 g / L, ammonium chloride concentration of 5 g / L, glucose concentration of 12 g / L, and PBS solution at pH 8.5 as solvent. The reaction was carried out at 35℃ with a shaking speed of 200 rpm for 12 h. HPLC analysis showed that the nicotinamide yield was 7.5 g / L.

[0067] Example 19 According to the induction expression method described in Example 2, E.coli After BL21(DE3) / pCDFDuet-ScPHBH-ReHAAO+pACYCDuet-HcPAD-AtAAL induction, bacterial cells were collected and placed in a 50 mL system with a final cell concentration of 6 g / L, sodium anthranilate concentration of 8 g / L, ammonium chloride concentration of 5 g / L, glucose concentration of 9 g / L, and PBS solution at pH 9.0. The reaction was carried out at 35℃ with a shaking speed of 200 rpm for 12 h. HPLC analysis showed that the nicotinamide yield was 6.1 g / L.

[0068] Example 20 According to the induction expression method described in Example 2, E.coliAfter BL21(DE3) / pCDFDuet-ScPHBH-ReHAAO+pACYCDuet-HcPAD-AtAAL induction, bacterial cells were collected and placed in a 50 mL system with a final cell concentration of 18 g / L, sodium anthranilate concentration of 47 g / L, ammonium chloride concentration of 16 g / L, glucose concentration of 49 g / L, and PBS solution at pH 7.5. The reaction was carried out at 15℃ with a shaking speed of 200 rpm for 24 h. HPLC analysis showed that the nicotinamide yield was 35.2 g / L.

[0069] Example 21 According to the induction expression method described in Example 2, E.coli After BL21(DE3) / pCDFDuet-ScPHBH-ReHAAO+pACYCDuet-HcPAD-AtAAL induction, bacterial cells were collected and placed in a 50 mL system with a final cell concentration of 12 g / L, sodium anthranilate concentration of 32 g / L, ammonium chloride concentration of 11 g / L, glucose concentration of 33 g / L, and PBS solution at pH 7.5. The reaction was carried out at 25℃ with a shaking speed of 200 rpm for 24 h. HPLC analysis showed that the nicotinamide yield was 24.3 g / L.

[0070] Example 22 According to the induction expression method described in Example 2, E.coli After BL21(DE3) / pCDFDuet-ScPHBH-ReHAAO+pACYCDuet-HcPAD-AtAAL induction, bacterial cells were collected and placed in a 50 mL system with a final cell concentration of 15 g / L, sodium anthranilate concentration of 41 g / L, ammonium chloride concentration of 16 g / L, glucose concentration of 42 g / L, and PBS solution at pH 7.5. The reaction was carried out at 40℃ with a shaking speed of 200 rpm for 24 h. HPLC analysis showed that the nicotinamide yield was 30.7 g / L.

[0071] Example 23 This embodiment verifies the fermenter yield. Following the induced expression method described in Example 2, [the following is used]... E.coliAfter BL21(DE3) / pCDFDuet-ScPHBH-ReHAAO+pACYCDuet-HcPAD-AtAAL induction, bacterial cells were collected and reacted in a 3L system with an initial concentration of sodium anthranilate of 80 g / L, an initial concentration of ammonium chloride of 35 g / L, an initial concentration of glucose of 80 g / L, and a final cell concentration of 20 g / L. The solvent was PBS solution, pH 8.0, at 30℃ and 600 rpm. During the reaction, a mixed solution of sodium anthranilate and ammonium chloride was added at a uniform flow rate of 10 g / L / h and 3.5 g / L / h, respectively. After 20 h of reaction, the total amount of sodium anthranilate added was 280 g / L and the total amount of ammonium chloride added was 115 g / L. HPLC analysis showed that the nicotinamide yield was 213.2 g / L.

[0072] As can be seen from the above embodiments, the yield can reach over 99% whether using shake flask fermentation or fermenter production. Compared to Chinese patent CN109593750B, which is titled "A Nitrile Hydrate Hydrate Mutant, Genetically Engineered Bacteria Containing the Mutant and Its Application," the nicotinamide yield disclosed in that patent is around 95%. The production method of this invention shows a significant improvement. Moreover, the nicotinamide yield per unit cell of this invention reaches 10.66 g / g wet cell, while the yield of recombinant bacteria with OD150 (corresponding to a wet cell weight of over 200 g / L) in CN109593750B is 680 g / L. After conversion, its nicotinamide yield per unit cell is 3.4 g / g wet cell. Therefore, in terms of nicotinamide yield per unit cell, the recombinant bacteria of this invention has a greater advantage.

[0073] Comparative Example 1 According to the induction expression method described in Example 2, E.coli After BL21(DE3) / pCDFDuet-ScPHBH-ReHAAO+pACYCDuet-HcPAD-AtAAL induction, bacterial cells were collected and placed in a 50 mL system with a final cell concentration of 36 g / L, sodium anthranilate concentration of 95 g / L, ammonium chloride concentration of 40 g / L, glucose concentration of 100 g / L, and PBS solution at pH 7.5. The reaction was carried out at 35℃ with a shaking speed of 200 rpm for 36 h. HPLC analysis showed that the nicotinamide yield was 9.9 g / L.

[0074] Comparative Example 2 According to the induction expression method described in Example 2, E.coliAfter BL21(DE3) / pCDFDuet-ScPHBH-ReHAAO+pACYCDuet-HcPAD-AtAAL induction, bacterial cells were collected and placed in a 50 mL system with a final cell concentration of 15 g / L, sodium anthranilate concentration of 40 g / L, ammonium chloride concentration of 19 g / L, glucose concentration of 43 g / L, and PBS solution at pH 5.5. The reaction was carried out at 35℃ with a shaking speed of 200 rpm for 36 h. HPLC analysis showed that the nicotinamide yield was 3.9 g / L.

[0075] Comparative Example 3 According to the induction expression method described in Example 2, E.coli After BL21(DE3) / pCDFDuet-ScPHBH-ReHAAO+pACYCDuet-HcPAD-AtAAL induction, bacterial cells were collected and placed in a 50 mL system with a final cell concentration of 9 g / L, sodium anthranilate concentration of 32 g / L, ammonium chloride concentration of 15 g / L, glucose concentration of 35 g / L, and PBS solution at pH 9.5. The reaction was carried out at 35℃ with a shaking speed of 200 rpm for 36 h. HPLC analysis showed that the nicotinamide yield was 4.3 g / L.

[0076] Comparative Example 4 According to the induction expression method described in Example 2, E.coli After BL21(DE3) / pCDFDuet-ScPHBH-ReHAAO+pACYCDuet-HcPAD-AtAAL induction, bacterial cells were collected and placed in a 50 mL system with a final cell concentration of 12 g / L, sodium anthranilate concentration of 35 g / L, ammonium chloride concentration of 15 g / L, glucose concentration of 34 g / L, and PBS solution at pH 7.5. The reaction was carried out at 10℃ with a shaking speed of 200 rpm for 36 h. HPLC analysis showed that the nicotinamide yield was 5.1 g / L.

[0077] Comparative Example 5 According to the induction expression method described in Example 2, E.coliAfter BL21(DE3) / pCDFDuet-ScPHBH-ReHAAO+pACYCDuet-HcPAD-AtAAL induction, bacterial cells were collected and placed in a 50 mL system with a final cell concentration of 18 g / L, sodium anthranilate concentration of 48 g / L, ammonium chloride concentration of 18 g / L, glucose concentration of 50 g / L, and PBS solution at pH 8.0. The reaction was carried out at 45℃ with a shaking speed of 200 rpm for 36 h. HPLC analysis showed that the nicotinamide yield was 6.2 g / L.

[0078] Comparative Example 6 According to the induction expression method described in Example 2, E.coli After BL21(DE3) / pCDFDuet-ScPHBH-ReHAAO+pACYCDuet-HcPAD-AtAAL induction, bacterial cells were collected and placed in a 50 mL system with a final cell concentration of 0.5 g / L, sodium anthranilate concentration of 0.5 g / L, ammonium chloride concentration of 3 g / L, glucose concentration of 3 g / L, and PBS solution at pH 8.0. The reaction was carried out at 30℃ with a shaking speed of 200 rpm for 36 h. HPLC analysis showed that the nicotinamide yield was 0.1 g / L.

[0079] The yield results from Examples 4-22 and Comparative Examples 1-6 show that the reaction conditions with better synthesis results are: sodium anthranilate 1-80 g / L, ammonium chloride 5-35 g / L, glucose 5-80 g / L, wet bacterial cells 1-30 g / L, pH 6.0-9.0, temperature 15-40℃, rotation speed 100-250 rpm, and reaction time 8-24 h.

[0080] The above description is merely a preferred embodiment of the present invention and is not intended to limit the invention. Various modifications and variations can be made to the present invention by those skilled in the art. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of the present invention should be included within the scope of protection of the present invention.

Claims

1. A recombinant bacterium for producing nicotinamide, characterized in that, The recombinant bacteria express: ScPHBH (amino acid sequence as shown in SEQ ID NO. 2), ReHAAO (amino acid sequence as shown in SEQ ID NO. 6), HcPAD (amino acid sequence as shown in SEQ ID NO. 10), and PsAAL (amino acid sequence as shown in SEQ ID NO. 14); or Amino acid sequences as shown in SEQ ID NO.4 (BpPHBH), SEQ ID NO.6 (ReHAAO), SEQ ID NO.10 (HcPAD), and SEQ ID NO.14 (PsAAL); or Amino acid sequences as shown in SEQ ID NO. 2 (ScPHBH), SEQ ID NO. 8 (FgHAAO), SEQ ID NO. 10 (HcPAD), and SEQ ID NO. 14 (PsAAL); or Amino acid sequences as shown in SEQ ID NO. 2 (ScPHBH), SEQ ID NO. 6 (ReHAAO), SEQ ID NO. 12 (LcPAD), and SEQ ID NO. 14 (PsAAL); or Amino acid sequences as shown in SEQ ID NO.2 (ScPHBH), SEQ ID NO.6 (ReHAAO), SEQ ID NO.10 (HcPAD), and SEQ ID NO.16 (AtAAL); or Amino acid sequences as shown in SEQ ID NO.4 (BpPHBH), SEQ ID NO.8 (FgHAAO), SEQ ID NO.10 (HcPAD), and SEQ ID NO.14 (PsAAL); or Amino acid sequences as shown in SEQ ID NO. 4 (BpPHBH), SEQ ID NO. 6 (ReHAAO), SEQ ID NO. 12 (LcPAD), and SEQ ID NO. 14 (PsAAL); or Amino acid sequences as shown in SEQ ID NO.4 (BpPHBH), SEQ ID NO.6 (ReHAAO), SEQ ID NO.10 (HcPAD), and SEQ ID NO.16 (AtAAL); or The amino acid sequences are BpPHBH as shown in SEQ ID NO.4, FgHAAO as shown in SEQ ID NO.8, LcPAD as shown in SEQ ID NO.12, and PsAAL as shown in SEQ ID NO.14; The starting strain of the recombinant bacteria is Escherichia coli BL21.

2. The recombinant bacteria according to claim 1, characterized in that, The nucleotide sequence of the ScPHBH encoding gene is shown in SEQ ID NO.1, and the nucleotide sequence of the BpPHBH encoding gene is shown in SEQ ID NO.3; The nucleotide sequence of the ReHAAO encoding gene is shown in SEQ ID NO.5, and the nucleotide sequence of the FgHAAO encoding gene is shown in SEQ ID NO.7; The nucleotide sequence of the HcPAD encoding gene is shown in SEQ ID NO.9, and the nucleotide sequence of the LcPAD encoding gene is shown in SEQ ID NO.

11. The nucleotide sequence of the PsAAL encoding gene is shown in SEQ ID NO.13, and the nucleotide sequence of the AtAAL encoding gene is shown in SEQ ID NO.

15.

3. The method for preparing the recombinant bacteria according to claim 1 or 2, characterized in that, include: The genes encoding the ScPHBH or BpPHBH, the ReHAAO or FgHAAO, the HcPAD or LcPAD, and the PsAAL or AtAAL are inserted into an expression vector to obtain a recombinant vector. The recombinant vector is then introduced into Escherichia coli to obtain the recombinant bacteria. The expression vectors are pCDFDuet-1 and pACYCDuet-1; The recombinant vector is selected from: pCDFDuet-ScPHBH-ReHAAO, pACYCDuet-HcPAD-PsAAL, pCDFDuet-BpPHBH-ReHAAO, pCDFDuet-ScPHBH-FgHAAO, pACYCDuet-LcPAD-PsAAL, pACYCDuet-HcPAD-AtAAL, and pCDFDuet-BpPHBH-FgHAAO.

4. The use of the recombinant bacteria according to claim 1 or 2 in the following aspects: (1) Catalytic synthesis of nicotinamide; (2) Prepare products for catalytic synthesis of nicotinamide.

5. A biocatalyst, characterized in that, It contains the recombinant bacteria as described in claim 1 or 2.

6. A method for producing nicotinamide, characterized in that, include: The recombinant bacteria described in claim 1 or 2 are added to a solution containing sodium anthranilate for whole-cell catalysis to obtain nicotinamide.

7. The method according to claim 6, characterized in that, The whole-cell catalytic production system includes: sodium anthranilate 1~80 g / L, ammonium chloride 5~35 g / L, glucose 5~80 g / L, and wet bacterial cells of the recombinant bacteria 1~30 g / L; The whole-cell catalytic production system has a pH of 6.0~9.0, a temperature of 15~40℃, a rotation speed of 100~250 rpm, and a reaction time of 8~24 h.

Citation Information

Patent Citations

  • A nitrile hydratase mutant, a genetically engineered bacterium containing the mutant, and their applications

    CN109593750B

  • Biosynthesis method of nicotinamide adenine dinucleotide compound

    CN117431283A

  • A method for co-production of 1, 3-propanediol, 2,3-butanediol and polyhydroxypropionic acid by fermentation of constructed genetic engineering bacteria

    WO2009140929A1